UnitedHealth Group (NYSE:UNH) Stock Price Down 0%

UnitedHealth Group Incorporated (NYSE:UNH) fell 0% during mid-day trading on Friday . The stock traded as low as $491.40 and last traded at $493.77. 635,826 shares were traded during mid-day trading, a decline of 86% from the average session volume of 4,480,454 shares. The stock had previously closed at $493.86.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on UNH. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 10th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Finally, Stephens reaffirmed an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Trading Up 0.3 %

The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The firm has a market cap of $455.76 billion, a PE ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. The stock’s 50 day simple moving average is $485.84 and its 200 day simple moving average is $514.14.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the business posted $6.26 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 45.97%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

Institutional Trading of UnitedHealth Group

Hedge funds and other institutional investors have recently modified their holdings of the business. Verdence Capital Advisors LLC grew its position in UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after purchasing an additional 342 shares during the last quarter. Ascension Capital Advisors Inc. purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $216,000. Bellecapital International Ltd. grew its position in UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after purchasing an additional 193 shares during the last quarter. Great Valley Advisor Group Inc. boosted its holdings in shares of UnitedHealth Group by 5.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after acquiring an additional 1,884 shares during the last quarter. Finally, Rise Advisors LLC boosted its holdings in shares of UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock valued at $112,000 after acquiring an additional 163 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.